BRAZIER™️ by OSJ Rx
Titrating terpenes & cannabinoids to effectually deliver thrice filtered microdoses for chronic pain symptoms relief, et.al.
The BRAZIER™️ MDI-P is the first medical grade patent device, system and method for microdosing prescribed cannabis in dried flower form, void of harmful or potentially harmful constituents.
Clinical Trials will help physicians more accurately prescribe treatments based on registered patients feedback. More research is needed which is why OSJ Rx being an ancillary MedTech to all botanical inhalation clinical trials we seek continued collaborations with clinicians, physicians and registered patient participants.
For more information please visit:
OfficialBRAZIER.com
#NYCannabis, #cannabisismedicine, #cannabistalk101, #cannabis, #microdose, #microdosing, #medicalcannabis
@cannabisscienceconference
source
